| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 532* | 2021 |
| Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group D Timmerman, L Ameye, D Fischerova, E Epstein, GB Melis, S Guerriero, ... Bmj 341, 2010 | 531 | 2010 |
| Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary … B Van Calster, K Van Hoorde, L Valentin, AC Testa, D Fischerova, ... Bmj 349, 2014 | 442 | 2014 |
| Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group D Timmerman, B Van Calster, A Testa, L Savelli, D Fischerova, ... American journal of obstetrics and gynecology 214 (4), 424-437, 2016 | 342 | 2016 |
| Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients J de Haan, M Verheecke, K Van Calsteren, B Van Calster, RG Shmakov, ... The Lancet Oncology 19 (3), 337-346, 2018 | 335 | 2018 |
| Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting F Amant, MJ Halaska, M Fumagalli, KD Steffensen, C Lok, ... International Journal of Gynecologic Cancer 24 (3), 2014 | 289 | 2014 |
| microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition A Parikh, C Lee, P Joseph, S Marchini, A Baccarini, V Kolev, C Romualdi, ... Nature communications 5 (1), 2977, 2014 | 285 | 2014 |
| Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study C Collaborative. J Clin Oncol 39 (1), 66-78, 2021 | 264 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 232 | 2021 |
| PRL-3 phosphatase is implicated in ovarian cancer growth F Polato, A Codegoni, R Fruscio, P Perego, C Mangioni, S Saha, ... Clinical cancer research 11 (19), 6835-6839, 2005 | 231 | 2005 |
| Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group D Timmerman, B Van Calster, AC Testa, S Guerriero, D Fischerova, ... Ultrasound in Obstetrics and Gynecology 36 (2), 226-234, 2010 | 229 | 2010 |
| Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting F Amant, P Berveiller, IA Boere, E Cardonick, R Fruscio, M Fumagalli, ... Annals of Oncology 30 (10), 1601-1612, 2019 | 227 | 2019 |
| Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections S Marchini, D Cavalieri, R Fruscio, E Calura, D Garavaglia, IF Nerini, ... The lancet oncology 12 (3), 273-285, 2011 | 222 | 2011 |
| SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 … L Chiva, V Zanagnolo, D Querleu, N Martin-Calvo, J Arévalo-Serrano, ... International Journal of Gynecologic Cancer 30 (9), 2020 | 205 | 2020 |
| Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer S Marchini, R Fruscio, L Clivio, L Beltrame, L Porcu, IF Nerini, D Cavalieri, ... European journal of cancer 49 (2), 520-530, 2013 | 190 | 2013 |
| Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, ... Journal of Experimental Medicine 216 (3), 688-703, 2019 | 172 | 2019 |
| Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series R Fruscio, S Corso, L Ceppi, D Garavaglia, A Garbi, I Floriani, D Franchi, ... Annals of oncology 24 (1), 138-144, 2013 | 172 | 2013 |
| Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study W Froyman, C Landolfo, B De Cock, L Wynants, P Sladkevicius, AC Testa, ... The Lancet Oncology 20 (3), 448-458, 2019 | 158 | 2019 |
| A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP … AA Lissoni, N Colombo, A Pellegrino, G Parma, P Zola, D Katsaros, ... Annals of oncology 20 (4), 660-665, 2009 | 146 | 2009 |
| Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome A Pellegrino, E Vizza, R Fruscio, A Villa, G Corrado, M Villa, T Dell'Anna, ... European Journal of Surgical Oncology (EJSO) 35 (1), 98-103, 2009 | 141 | 2009 |
Dirk TimmermanProfessor Gynecology, KU Leuven; Visiting Professor Imperial College London; Sacro Cuore RomeVerified email at uzleuven.be
